Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05111002 · ClinicalTrials.gov registry record · Phase 1
Lefamulin for M. Genitalium Treatment Failures
A Phase 1 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT05111002 is a Phase 1 study that was terminated before completion, run by University of Washington. The registered enrollment target is 12 participants.
The verdict
NCT05111002, a Phase 1 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this drug study is to find out whether the antibiotic lefamulin (trade name Xenleta) will cure Mycoplasma genitalium infections that have not been cured by prior antibiotics while finding out whether it is more effective if the antibiotic doxycycline is taken first.
Interventions
- DRUG Doxycycline
- DRUG Lefamulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-04-22 |
| Est. Completion | 2023-11-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05111002
The ClinicalTrials.gov registry entry for NCT05111002 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Doxycycline is the first listed.
NCT05111002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05111002 about?
NCT05111002 is a clinical study titled "Lefamulin for M. Genitalium Treatment Failures". The purpose of this drug study is to find out whether the antibiotic lefamulin (trade name Xenleta) will cure Mycoplasma genitalium infections that have not been cured by prior antibiotics while finding out whether it is more effective if the antibiotic doxycycline is taken first.
What is the current status of trial NCT05111002?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2022-04-22. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT05111002?
The interventions under investigation include: Doxycycline (DRUG), Lefamulin (DRUG).
Who is sponsoring clinical trial NCT05111002?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.